SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001558370-22-004430
Filing Date
2022-03-28
Accepted
2022-03-28 08:00:29
Documents
12
Period of Report
2022-04-21

Document Format Files

Seq Description Document Type Size
1 DEF 14A tmb-20220421xdef14a.htm DEF 14A 273262
2 GRAPHIC tmb-20220421xdef14a014.jpg GRAPHIC 47439
3 GRAPHIC tmb-20220421xdef14a008.jpg GRAPHIC 1911
4 GRAPHIC tmb-20220421xdef14a007.jpg GRAPHIC 1849
5 GRAPHIC tmb-20220421xdef14a016.jpg GRAPHIC 61462
6 GRAPHIC tmb-20220421xdef14a015.jpg GRAPHIC 52531
7 GRAPHIC tmb-20220421xdef14a011.jpg GRAPHIC 52445
8 GRAPHIC tmb-20220421xdef14a012.jpg GRAPHIC 44525
9 GRAPHIC tmb-20220421xdef14a001.jpg GRAPHIC 8238
10 GRAPHIC tmb-20220421xdef14a013.jpg GRAPHIC 52528
11 GRAPHIC tmb-20220421xdef14a006.jpg GRAPHIC 1941
12 GRAPHIC tmb-20220421xdef14a002.jpg GRAPHIC 20506
  Complete submission text file 0001558370-22-004430.txt   751555
Mailing Address 500 COLLEGE ROAD EAST SUITE 310 PRINCETON NJ 08540-6635
Business Address 500 COLLEGE ROAD EAST SUITE 310 PRINCETON NJ 08540-6635 609-683-1880
AGILE THERAPEUTICS INC (Filer) CIK: 0001261249 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36464 | Film No.: 22773220
SIC: 2834 Pharmaceutical Preparations